JP2020511940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511940A5 JP2020511940A5 JP2019530426A JP2019530426A JP2020511940A5 JP 2020511940 A5 JP2020511940 A5 JP 2020511940A5 JP 2019530426 A JP2019530426 A JP 2019530426A JP 2019530426 A JP2019530426 A JP 2019530426A JP 2020511940 A5 JP2020511940 A5 JP 2020511940A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- acid sequence
- amino acid
- seq
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662432033P | 2016-12-09 | 2016-12-09 | |
| US62/432,033 | 2016-12-09 | ||
| US201762465378P | 2017-03-01 | 2017-03-01 | |
| US62/465,378 | 2017-03-01 | ||
| PCT/IB2017/057759 WO2018104919A1 (en) | 2016-12-09 | 2017-12-08 | Chimpanzee adenovirus constructs with lyssavirus antigens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511940A JP2020511940A (ja) | 2020-04-23 |
| JP2020511940A5 true JP2020511940A5 (enExample) | 2021-01-21 |
| JP7118062B2 JP7118062B2 (ja) | 2022-08-15 |
Family
ID=60955374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530426A Expired - Fee Related JP7118062B2 (ja) | 2016-12-09 | 2017-12-08 | リサウイルス抗原を有するチンパンジーアデノウイルス構築物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20220112245A2 (enExample) |
| EP (1) | EP3551644B1 (enExample) |
| JP (1) | JP7118062B2 (enExample) |
| CN (1) | CN110036020A (enExample) |
| BR (1) | BR112019010275A2 (enExample) |
| CA (1) | CA3045976A1 (enExample) |
| ES (1) | ES2959811T3 (enExample) |
| MX (1) | MX2019006722A (enExample) |
| WO (1) | WO2018104919A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| ES2899913T3 (es) | 2014-09-24 | 2022-03-15 | Salk Inst For Biological Studi | Virus tumorales oncolíticos y métodos de uso |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP3390645B1 (en) | 2016-02-23 | 2022-09-14 | Salk Institute for Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| AU2017375633C1 (en) | 2016-12-12 | 2023-04-27 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| KR102945203B1 (ko) | 2017-05-08 | 2026-03-31 | 시애틀 프로젝트 코포레이션 | 알파바이러스 신생항원 벡터 |
| CN111108203A (zh) * | 2017-07-17 | 2020-05-05 | 葛兰素史密丝克莱恩生物有限公司 | 狂犬病病毒抗原构建体 |
| BR112020019942A2 (pt) | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| KR102077772B1 (ko) * | 2018-11-29 | 2020-02-17 | 주식회사 바이오앱 | 광견병 예방용 백신 조성물 및 이의 제조 방법 |
| EP3893927A1 (en) | 2018-12-14 | 2021-10-20 | GlaxoSmithKline Biologicals S.A. | Heterologous prime boost vaccine compositions and methods |
| SG11202113187WA (en) | 2019-05-30 | 2021-12-30 | Gritstone Bio Inc | Modified adenoviruses |
| CN113966228A (zh) * | 2019-06-11 | 2022-01-21 | 葛兰素史密斯克莱生物公司 | 黏膜疫苗配制剂 |
| WO2021245611A1 (en) | 2020-06-05 | 2021-12-09 | Glaxosmithkline Biologicals Sa | Modified betacoronavirus spike proteins |
| CN112210565B (zh) * | 2020-10-15 | 2022-07-29 | 中国科学院深圳先进技术研究院 | 一种g基因及其在高效逆向跨单突触中的应用 |
| WO2022077330A1 (zh) * | 2020-10-15 | 2022-04-21 | 中国科学院深圳先进技术研究院 | 一种新型g基因及其在高效逆向跨单突触中的应用 |
| CN114591922A (zh) * | 2022-03-30 | 2022-06-07 | 长睿生物技术(成都)有限公司 | 一种表达狂犬病毒g蛋白的重组黑猩猩源腺病毒及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698202A (en) * | 1995-06-05 | 1997-12-16 | The Wistar Institute Of Anatomy & Biology | Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier |
| AU2002308713B2 (en) * | 2001-06-22 | 2008-05-15 | The Trustees Of The University Of Pennsylvania | Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| JP4814800B2 (ja) * | 2004-01-23 | 2011-11-16 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | チンパンジーアデノウイルスワクチン担体 |
| CN102131920B (zh) * | 2007-11-28 | 2013-11-06 | 宾夕法尼亚大学托管会 | 猿猴亚家族C腺病毒SAdV-40、-31和-34及其应用 |
| HUE039908T2 (hu) * | 2009-02-02 | 2019-02-28 | Glaxosmithkline Biologicals Sa | Majom adenovírusból származó nukleinsav- és aminosav-szekvenciák, azt tartalmazó vektorok és alkalmazásuk |
| WO2010085984A1 (en) | 2009-02-02 | 2010-08-05 | Okairos Ag | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| JP6091435B2 (ja) | 2011-02-22 | 2017-03-08 | カリフォルニア インスティチュート オブ テクノロジー | アデノ随伴ウイルス（ａａｖ）ベクターを用いたタンパク質の送達 |
| CA2850627C (en) | 2011-10-05 | 2024-05-21 | Genvec, Inc. | Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| CA2851251C (en) | 2011-10-05 | 2023-09-12 | Genvec, Inc. | Simian (gorilla) adenovirus or adenoviral vectors and methods of use |
| BR112014008167B1 (pt) | 2011-10-05 | 2022-05-24 | Genvec Inc | Adenovírus ou vetor adenoviral e composição os compreendendo |
| JPWO2015119291A1 (ja) * | 2014-02-10 | 2017-03-30 | 有限会社生物資源研究所 | ウイルス様粒子 |
| EP3154576A1 (en) * | 2014-06-13 | 2017-04-19 | GlaxoSmithKline Biologicals S.A. | Immunogenic combinations |
| WO2016198621A1 (en) * | 2015-06-12 | 2016-12-15 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
-
2017
- 2017-12-08 JP JP2019530426A patent/JP7118062B2/ja not_active Expired - Fee Related
- 2017-12-08 CN CN201780074503.5A patent/CN110036020A/zh active Pending
- 2017-12-08 EP EP17828782.7A patent/EP3551644B1/en active Active
- 2017-12-08 CA CA3045976A patent/CA3045976A1/en not_active Abandoned
- 2017-12-08 BR BR112019010275A patent/BR112019010275A2/pt not_active Application Discontinuation
- 2017-12-08 WO PCT/IB2017/057759 patent/WO2018104919A1/en not_active Ceased
- 2017-12-08 ES ES17828782T patent/ES2959811T3/es active Active
- 2017-12-08 MX MX2019006722A patent/MX2019006722A/es unknown
- 2017-12-08 US US16/467,569 patent/US20220112245A2/en not_active Abandoned
-
2022
- 2022-12-05 US US18/075,064 patent/US20230158134A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111108192B (zh) | 非人类人猿腺病毒核酸序列和氨基酸序列、含有其的载体及其用途 | |
| JP2020511114A5 (enExample) | ||
| JP2018523980A5 (enExample) | ||
| CN105112428B (zh) | 猿腺病毒核酸和氨基酸序列，包含其的载体及其用途 | |
| JP2018524977A5 (enExample) | ||
| JP2014516536A5 (enExample) | ||
| JP2015057052A5 (enExample) | ||
| US20210269827A1 (en) | Modified serotype 28 adenoviral vectors | |
| CN110300597A (zh) | 腺病毒多核苷酸和多肽 | |
| US20120225470A1 (en) | Methods of propagating monkey adenoviral vectors | |
| US12180512B2 (en) | Simian adenoviral vectors with two expression cassettes | |
| JP2026082958A (ja) | ゴリラ・アデノウイルスの核酸配列およびアミノ酸配列、それを含むベクター、およびそれらの使用 | |
| US20220364115A1 (en) | Enhanced promoter | |
| HK40031047A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| HK40031047B (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| NZ759892B2 (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| WO2004108939A2 (en) | Bav packaging regions and e1 transcriptional control regions |